HR4993119th CongressWALLET

Joe Fiandra Access to Home Infusion Act of 2025

Sponsored By: Representative Fitzpatrick

In Committee

Summary

Expands Medicare Part B to cover external infusion pumps and certain supervised home infusion drugs. This bill would set specific criteria for which pumps and non-self-administerable infusion drugs qualify and phase in coverage after one year, while requiring patients be told about cost sharing for home infusion versus other settings.

Show full summary
  • Patients and households: Would allow beneficiaries to get covered home infusion when a drug's FDA labeling says it needs professional administration and the treatment is given at least 12 times per year or at infusion rates that require an external pump. It also requires clear notice to patients about how cost sharing for home infusion compares to other care settings.
  • Home infusion suppliers and clinicians: Creates a defined category of a qualified home infusion therapy supplier who must administer or supervise the infusion in the patient's home for Medicare to cover the pump, drug, and related supplies.
  • Medicare coverage and timing: Treats certain external pumps and related supplies as meeting the "home-use" durable medical equipment standard when the bill's criteria are met. Coverage begins the first calendar quarter after one year from enactment.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

More Medicare coverage for home infusion

If enacted, Medicare would cover an external infusion pump, supplies, and some home infusion drugs used at home. Coverage would start the first calendar quarter that begins one year after the bill becomes law. To qualify, the drug’s FDA label must say a health professional should give or supervise it, and a qualified home infusion supplier must do that in your home. The drug must be infused at least 12 times per year or at rates that need an external pump. HHS would also make sure patients are told their cost sharing for home infusion and how it compares to other care settings.

Sponsors & CoSponsors

Sponsor

Fitzpatrick

PA • R

Cosponsors

  • Dunn (FL)

    FL • R

    Sponsored 8/19/2025

  • Soto

    FL • D

    Sponsored 8/19/2025

  • Vindman

    VA • D

    Sponsored 9/15/2025

  • Gottheimer

    NJ • D

    Sponsored 9/19/2025

  • Ross

    NC • D

    Sponsored 10/17/2025

  • Lawler

    NY • R

    Sponsored 1/12/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in